- Home
- FSP vs BRNS Comparison
FSP vs BRNS Comparison
Compare FSP & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FSP | BRNS |
|---|---|---|
| Founded | 1981 | 2016 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 64.7M | 55.9M |
| IPO Year | 2001 | 2021 |
Fundamental Metrics
Financial Performance| Metric | FSP | BRNS |
|---|---|---|
| Price | $0.60 | $0.68 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $4.00 |
| AVG Volume (30 Days) | ★ 614.8K | 46.1K |
| Earning Date | 01-01-0001 | 06-12-2026 |
| Dividend Yield | ★ 6.67% | N/A |
| EPS Growth | ★ 15.69 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $107,162,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.59 | $0.56 |
| 52 Week High | $1.93 | $2.91 |
Technical Indicators
Market Signals| Indicator | FSP | BRNS |
|---|---|---|
| Relative Strength Index (RSI) | 33.03 | 54.03 |
| Support Level | N/A | $0.56 |
| Resistance Level | $0.89 | $0.76 |
| Average True Range (ATR) | 0.06 | 0.05 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 3.39 | 75.06 |
Price Performance
Historical ComparisonAbout FSP Franklin Street Properties Corp.
Franklin Street Properties Corp is a real estate investment trust. The company is focused on commercial real estate investments in office markets and currently operate in only one segment: real estate operations. The principal revenue sources for its real estate operations include rental income from real estate leasing, property dispositions and fee income from asset/property management and development. The company provides asset management, property management, property accounting, investor and/or development services to its portfolio and Sponsored REIT through the company's subsidiaries.
About BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.